Application of optical coherence tomography in percutaneous coronary intervention

Circulation Journal

Volumn 76, Issue 9, 2012, Pages 2076-2083

  Kubo, Takashi ^a   Tanaka, Atsushi ^a   Kitabata, Hironori ^a   Ino, Yasushi ^a   Tanimoto, Takashi ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Drug eluting stents; Optical coherence tomography; Percutaneous coronary intervention

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTERY LESION; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR RESPONSE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISSECTION; CORONARY STENT; DRUG ELUTING STENT; FOLLOW UP; FREQUENCY DOMAIN OPTICAL COHERENCE TOMOGRAPHY; HUMAN; IMAGE QUALITY; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; STENT MALAPPOSITION; STENT THROMBOSIS; TISSUE PROTRUSION;

CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PROSTHESIS FAILURE; TOMOGRAPHY, OPTICAL COHERENCE; TROPONIN I;

EID: 84865484335     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0828     Document Type: Review

References (41)

1. Guagliumi G, Akasaka T, Sirbu V, Kubo T. Optical coherence tomography. In: Topol T, editor. Textbook of interventional cardiology, 6th edn. St. Louis, MO: Elsevier, 2011; 842-857.
2. Kubo T, Akasaka T. Identification of vulnerable plaques with optical coherence tomography. In: PeŠek K, editor. Atherosclerotic cardiovascular disease. Rijeka, Croatia: InTech, 2011; 71-88.
3. Takarada S, Imanishi T, Liu Y, Ikejima H, Tsujioka H, Kuroi A, et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv 2010; 75: 202-206.
4. Ozaki Y, Kitabata H, Tsujioka H, Hosokawa S, Kashiwagi M, Ishibashi K, et al. Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. Circ J 2012; 76: 922-927.
5. Tsuchida K, van der Giessen WJ, Patterson M, Tanimoto S, García-García HM, Regar E, et al. In vivo validation of a novel three-dimensional quantitative coronary angiography system (CardiOp-B): Comparison with a conventional two-dimensional system (CAAS II) and with special reference to optical coherence tomography. EuroIntervention 2007; 3: 100-108.
6. Okamura T, Onuma Y, Garcia-Garcia HM, van Geuns RJ, Wykrzykowska JJ, Schultz C, et al. First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: A comparison with intravascular ultrasound and quantitative coronary angiography. EuroIntervention 2011; 6: 1037-1045.
7. Gonzalo N, Serruys PW, García-García HM, van Soest G, Okamura T, Ligthart J, et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. Rev Esp Cardiol 2009; 62: 615-624.
8. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: A comprehensive review clinical and research applications. JACC Cardiovasc Interv 2009; 2: 1035-1046.
9. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002; 106: 1640-1645.
10. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of culprit lesion morphology in acute myocardial infarction: Ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007; 50: 933-939.
11. Kubo T, Xu C, Wang Z, van Ditzhuijzen NS, Bezerra HG. Plaque and thrombus evaluation by optical coherence tomography. Int J Cardiovasc Imaging 2011; 27: 289-298.
12. Kume T, Okura H, Yamada R, Kawamoto T, Watanabe N, Neishi Y, et al. Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: An ex vivo validation and an initial in vivo feasibility study. Circ J 2009; 73: 1086-1091.
13. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T, et al. Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: An optical coherence tomography study. Eur Heart J 2009; 30: 1348-1355.
14. Ozaki Y, Tanaka A, Tanimoto T, Kitabata H, Kashiwagi M, Kubo T, et al. Thin-cap fibroatheroma as high-risk plaque for microvascular obstruction in patients with acute coronary syndrome. Circ Cardiovasc Imaging 2011; 4: 620-627.
15. Lee T, Yonetsu T, Koura K, Hishikari K, Murai T, Iwai T, et al. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation. Circ Cardiovasc Interv 2011; 4: 378-386.
16. Aziz S, Ramsdale DR. Chronic total occlusions: A stiff challenge requiring a major breakthrough: Is there light at the end of the tunnel? Heart 2005; 91: iii42-iii48.
17. Kume T, Okura H, Miyamoto Y, Yamada R, Saito K, Tamada T, et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation: Preliminary observation. Circ J 2012; 76: 698-703.
18. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500-1510.
19. Kubo T, Imanishi T, Kitabata H, Kuroi A, Ueno S, Yamano T, et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: A serial optical coherence tomography study. JACC Cardiovasc Imaging 2008; 1: 475-484.
20. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Garcia-Garcia HM, Onuma Y, et al. Relation between plaque type and dissections at the edges after stent implantation: An optical coherence tomography study. Int J Cardiol 2011; 150: 151-155.
21. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967.
22. Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ, et al. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 2008; 94: 566-570.
23. Takano M, Murakami D, Yamamoto M, Kurihara O, Murai K, Inami T, et al. Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: Comparison with paclitaxel-eluting stents. Int J Cardiol 2011 November 8 [E-pub ahead of print].
24. Tahara S, Bezerra HG, Sirbu V, Kyono H, Musumeci G, Rosenthal N, et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: A substudy of the ODESSA trial. Heart 2010; 96: 1574-1578.
25. Kubo T, Matsuo Y, Okumoto Y, Nakamura K, Kashiwagi M, Ishibashi K, et al. Diagnostic accuracy of 64-slice multislice computed tomography to assess coronary stent thrombosis as determined by intravascular optical coherence tomography. JACC Cardiovasc Imaging 2011; 4: 1040-1043.
26. Liu Y, Imanishi T, Kubo T, Tanaka A, Kitabata H, Tanimoto T, et al. Assessment by optical coherence tomography of stent struts across side branch: Comparison of bare-metal stents and drug-elution stents. Circ J 2011; 75: 106-112.
27. Guagliumi G, Capodanno D, Ikejima H, Bezerra HG, Sirbu V, Musumeci G, et al. Impact of different stent alloys on human vascular response to everolimus-eluting stent: An optical coherence tomography study: The OCTEVEREST. Catheter Cardiovasc Interv 2012 March 16 [E-pub ahead of print].
28. Kitabata H, Kubo T, Komukai K, Ishibashi K, Tanimoto T, Ino Y, et al. Effect of strut thickness on neointimal atherosclerotic change over an extended follow-up period (≥4 years) after bare-metal stent implantation: Intracoronary optical coherence tomography examination. Am Heart J 2012; 163: 608-616.
29. Guagliumi G, Ikejima H, Sirbu V, Bezerra H, Musumeci G, Lortkipanidze N, et al. Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: The Long OCT study (Optical Coherence Tomography in Long Lesions). JACC Cardiovasc Interv 2011; 4: 778-785.
30. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
31. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426-2434.
32. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, et al. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation 2011; 123: 2382-2391.
33. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drugeluting stent thrombosis: Findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv 2012; 5: 12-20.
34. Ino Y, Kubo T, Kitabata H, Shimamura K, Shiono Y, Orii M, et al. Impact of hinge motion on in-stent restenosis after sirolimus-eluting stent implantation. Circ J 2011; 75: 1878-1884.
35. Akasaka T. What can we expect in PCI in patients with chronic coronary artery disease. Indication of PCI for angiographically significant coronary artery stenosis without objective evidence of myocardial ischemia (Con). Circ J 2011; 75: 211-217.
36. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009; 158: 284-293.
37. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Sukmawan R, et al. Visualization of neointima formation by optical coherence tomography. Int Heart J 2005; 46: 1133-1136.
38. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010; 75: 961-963.
39. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 2009; 55: 26-32.
40. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011; 123: 2954-2963.
41. Farooq V, Gogas BD, Okamura T, Heo JH, Magro M, Gomez-Lara J, et al. Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: The potential for clinical application. Eur Heart J 2011 November 21 [E-pub ahead of print].